Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...
Vietnam Investment Review on MSN
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
The company confirmed the publication of its successful clinical case series in Frontiers in Immunology, a peer-reviewed scientific journal, and received confirmation from the U.S. Food and Drug ...
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient ...
Soleno Therapeutics (SLNO) announced a publication in the peer-reviewed Journal of Clinical Endocrinology and Metabolism. The paper, titled, ...
In picking Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services, President-elect Donald Trump is elevating a small but growing segment of the population that distrusts ...
Major depressive disorder (MDD) is a widespread and serious mental health condition that affects how people think, feel, and ...
The claim:In picking Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services, President-elect Donald Trump is elevating a small but growing segment of the population that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback